RE:RE:RE:The Bedrocan mistake continues...Stinks like profitability to me. CGC isn't running a non profit. Are you still invested?
JobeAustin wrote:
FalconM wrote: Are you kidding me, an extra $1.75 a gram? Big deal. If CGC strains are good and are in steady supply, they should be capitalizing on that. CGC has spent a lot on building a brand, and having slightly higher costs is a way for that to pay for itself. From what I've gathered, other LPs are going through some supply issues and could continue to as the market expands. It makes me confident that the next couple quarters CGC will outperform their competition... higher revenues, better products and more patient acquisitions. Then well see CGC's market cap rise above APH + MT + OGI once again... ($4.75-$5.00 a share).
it's not about the $1.75 a gram Falcon, it's about the picture that the language paints. We are a compassionate company with the patients best interest in mind.
here is the quote from Jan 25th 2015
"With limited insurance coverage and taxation, the affordability of medical cannabis can be a significant barrier to chronically ill patients obtaining the benefits of a medical marijuana program," said Jonathan Zaid, Member of Bedrocan Canada's Patient Advisory Board and Executive Director of Canadians for Fair Access to Medical Marijuana. "With its True Compassionate Pricing, Bedrocan is helping patients by making their medicine more affordable."
what changed??
something stinks....
Joe